Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleTEACHING CASE STUDIES

The Role of Scintigraphy in Confirmation of Suspected Brain Death

Prashant Jolepalem and Helena R. Balon
Journal of Nuclear Medicine Technology December 2013, 41 (4) 306-307; DOI: https://doi.org/10.2967/jnmt.113.127639
Prashant Jolepalem
Department of Diagnostic Radiology and Molecular Imaging, Oakland University William Beaumont School of Medicine and Beaumont Health System, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helena R. Balon
Department of Diagnostic Radiology and Molecular Imaging, Oakland University William Beaumont School of Medicine and Beaumont Health System, Royal Oak, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

We present a case illustrating how cerebral perfusion scintigraphy can be used to assist in crucial medical decision making in the intensive care setting for patients who are maintained on life support but are clinically suspected to have brain death. Cerebral perfusion scintigraphy can confirm brain death but cannot be used to diagnose it. 99mTc-HMPAO and 99mTc-ethylcysteinate dimer are the preferred imaging agents since they cross the blood–brain barrier.

  • neurology
  • pediatrics
  • SPECT
  • brain death
  • cerebral perfusion scintigraphy

This case report illustrates how cerebral perfusion scintigraphy can be used to assist in crucial medical decision making in the intensive care setting for patients who are maintained on life support but are clinically suspected to have brain death. The choice of radiotracers, imaging findings, and appropriate-use criteria will be discussed. The residents’ familiarity with interpretation criteria is critical, as these studies may have to be performed at any time of the day or night, and usually in an emotionally stressful situation.

CASE REPORT

A 3-y-old girl with a history of congenital adrenal hyperplasia presented with status epilepticus, hypoglycemia, and acute respiratory failure requiring mechanical ventilation after she had been found unresponsive by her parents. CT scanning on admission (Fig. 1) showed diffuse cerebral edema and loss of gray matter–white matter differentiation. Subsequent brain MR perfusion imaging (Fig. 2) demonstrated decreased perfusion in the thalami and basal ganglia and diffusely decreased perfusion in the cerebral cortex. MR spectroscopy demonstrated diffusely decreased N-acetylaspartic acid, indicating decreased neuronal activity; elevation of choline, indicating increased cell turnover; and the presence of lactate, indicating hypoxia (1). These findings were compatible with hypoxic brain injury. Follow-up CT performed 2 d later demonstrated impending transtentorial herniation (Fig. 3). Despite several interventions, the patient eventually showed no brain stem reflexes and had an isoelectric electroencephalogram. A scintigraphic cerebral perfusion study was ordered to confirm brain death before preparing for organ donation and discontinuation of life support. SPECT images of the head were obtained 20 min after intravenous injection of 407 MBq (11 mCi) of 99mTc-hexamethylpropyleneamine oxime (HMPAO). The images did not demonstrate any evidence of cerebral perfusion, whereas radiotracer activity was seen in the scalp, lacrimal glands, and salivary glands (Fig. 4). The patient was subsequently declared deceased.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Non–contrast-enhanced CT scan showing diffuse cerebral edema, bilateral sulcal effacement, and loss of gray matter–white matter differentiation. Occipital lobe is spared.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

(A) Regional cerebral blood flow MR perfusion study showing diffusely decreased perfusion to basal ganglia and thalami and mild reduction in cerebral cortex. (B) Cerebral perfusion study with normal findings is shown for comparison. (Courtesy of Department of MR Physics, Lund University, Lund, Sweden.)

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Follow-up CT scan showing progressive diffuse cerebral edema and interval development of basal cistern effacement. These findings were compatible with impending transtentorial herniation.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

SPECT images after 99mTc-HMPAO administration displayed as volume-rendered maximum-intensity projection (MIP) and tomographic slices in 3 planes. Images demonstrate activity in scalp, lacrimal glands, and salivary glands but absence of cerebral perfusion.

DISCUSSION

Cerebral perfusion scintigraphy is a simple, noninvasive method to confirm, but not diagnose, brain death (2). Before proceeding with the study, the patient should meet the criteria for the clinical diagnosis of brain death, which are as follows (3):

  • The patient must be in a deep coma with total absence of brain stem reflexes and spontaneous respiration.

  • Potentially reversible causes (drug intoxication, metabolic derangement, hypothermia) must be excluded.

  • The cause of the brain dysfunction must be diagnosed.

  • Clinical findings of brain death must be present for a defined period of observation (usually 6–24 h).

Radionuclide techniques do not require the withdrawal of medical therapy and are especially useful in the settings of hypothermia, drug overdose, shock, or an inconclusive physical examination (2,4). This study is often a critical and decisive step for the patient’s family to give their consent to withdraw care and harvest organs.

The increased intracranial pressure caused by necrosis, edema, and autolysis of the brain tissue impedes intracranial perfusion (4), thus making the brain death scan highly specific. For a study to be considered positive, there must be no perfusion to the brain. Expected activity can be seen in the scalp or projecting over the nose (known as the hot-nose sign) due to shunting of carotid blood flow to the maxillary branches (4,5).

99mTc-diethylenetriminepentaacetic acid (DTPA) in a dose of 370–740 MBq (10–20 mCi) can be used as an alternative radiopharmaceutical, but its use makes the study much more technically challenging because the flow images are the only diagnostic part of the study (4,5). Since 99mTc-DTPA is water-soluble and thus does not cross the intact blood–brain barrier, interpretation is solely dependent on seeing flow within the internal carotid artery, anterior cerebral artery, and middle cerebral artery on the anterior views of the radionuclide angiogram. Static images cannot differentiate between a normal brain and a dead brain, as there will be no intracranial activity in either. If acquisition of the radionuclide angiogram is unsuccessful, a repeated study becomes necessary. Fortunately, imaging can be repeated at a short interval because of rapid renal excretion of 99mTc-DTPA.

In most institutions, brain-specific agents such as 99mTc-HMPAO or 99mTc-ethylcysteinate dimer are preferred, as they are lipid-soluble and thus cross the blood–brain barrier and enter normally perfused cerebral tissue. Thus, use of these radiopharmaceuticals makes dynamic imaging a noncritical step in image acquisition (2,4,5). Additionally, they allow for imaging with suboptimal patient positioning, which is often the case because of the presence of life support equipment. The use of SPECT, when feasible, makes image interpretation even more straightforward.

CONCLUSION

Cerebral perfusion scintigraphy can be used to confirm, but not diagnose, clinically suspected brain death. 99mTc-HMPAO and 99mTc-ethylcysteinate dimer are the preferred imaging agents since they cross the blood–brain barrier.

DISCLOSURE

No potential conflict of interest relevant to this article was reported.

Footnotes

  • Published online Oct. 24, 2013.

REFERENCES

  1. 1.↵
    1. Edelman RR,
    2. Hesselink JR,
    3. Zlatkin MB,
    4. Crues JV
    1. Ross BD,
    2. Colletti P,
    3. Lin A
    . MR spectroscopy of the brain: neurospectroscopy. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues JV, eds. Clinical Magnetic Resonance Imaging. 3rd ed. Philadelphia, PA: Saunders-Elsevier; 2006:1840–1910.
  2. 2.↵
    1. Donohoe KJ,
    2. Agrawal G,
    3. Frey KA,
    4. et al
    . SNM practice guideline for brain death scintigraphy 2.0. J Nucl Med Technol. 2012;40:198–203.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Wijdicks EFM,
    2. Varelas PN,
    3. Gronseth GS,
    4. Greer DM
    . Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74:1911–1918.
    OpenUrlCrossRef
  4. 4.↵
    1. Ziessman HA,
    2. O’Malley JP,
    3. Thrall JH
    . Nuclear Medicine (The Requisites in Radiology). 3rd ed. Philadelphia, PA: Mosby; 2006:427f–430f, 435-438.
  5. 5.↵
    1. Mettler FA,
    2. Guiberteau MJ
    . Essentials of Nuclear Medicine. 6th ed. Philadelphia, PA: Elsevier Inc.; 2012:75–78.
  • Received for publication June 18, 2013.
  • Accepted for publication August 8, 2013.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 41 (4)
Journal of Nuclear Medicine Technology
Vol. 41, Issue 4
December 1, 2013
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Scintigraphy in Confirmation of Suspected Brain Death
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
The Role of Scintigraphy in Confirmation of Suspected Brain Death
Prashant Jolepalem, Helena R. Balon
Journal of Nuclear Medicine Technology Dec 2013, 41 (4) 306-307; DOI: 10.2967/jnmt.113.127639

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Role of Scintigraphy in Confirmation of Suspected Brain Death
Prashant Jolepalem, Helena R. Balon
Journal of Nuclear Medicine Technology Dec 2013, 41 (4) 306-307; DOI: 10.2967/jnmt.113.127639
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Brain Death Scintigraphy: Do Not Blow the Flow
  • Google Scholar

More in this TOC Section

  • High-Sensitivity Troponin Elevation in a Young Woman with Typical Chest Pain: The Heart of Matter
  • Prominent Right Ventricular Tracer Uptake: A Harbinger of Multivessel Coronary Artery Disease
  • SPECT/CT for Discrimination Between Active and Inactive Os Trigonum in Posterior Ankle Syndrome
Show more Teaching Case Studies

Similar Articles

Keywords

  • Neurology
  • pediatrics
  • SPECT
  • brain death
  • cerebral perfusion scintigraphy
SNMMI

© 2025 SNMMI

Powered by HighWire